Oxra-S 5/50 mg (Dapagliflozin/Sitagliptin)
| Active Ingredient | Dapagliflozin/Sitagliptin |
|---|---|
| Indication: | Type 2 diabetes |
| Manufacturer: | Sun Pharmaceutical Industries Ltd |
| Strength | 5mg/50mg |
| Packaging | 15 Tablets in 1 strip |
Oxra-S 5/50 mg is a combination oral medication that contains Dapagliflozin (5 mg) and Sitagliptin (50 mg), used in the management of type 2 diabetes mellitus. Dapagliflozin helps the kidneys remove excess glucose through urine, while Sitagliptin increases insulin release and decreases sugar production by the liver. Together, these components provide complementary mechanisms to effectively reduce and stabilize what is blood sugar levels without significant weight gain or hypoglycemia.
Oxra-S is especially beneficial for patients who need more than one medication to achieve glycemic control. It is usually taken once daily as prescribed by a healthcare professional. Along with medication, maintaining a healthy diet and regular physical activity is essential for effective diabetes management. Always follow your doctor’s instructions and monitor blood sugar regularly.








There are no reviews yet.